The risk for potential interaction can be minimized through an open dialogue regarding all prescription and over-the-counter medications, as well as dietary supplements, that are being consumed.
1. Center for Food Safety and Applied Nutrition, Food and Drug Administration, Department of Health and Human Services http://www.fda.gov/Food/DietarySupplements/default.htm. Accessed February 26, 2010.
2. Dietary Supplement and Nonprescription Drug Consumer Protection Act, Public Law 109–462, 109th Congress, Dec. 22, 2006.
3. Frankos VH, Street DA, O'Neill RK. FDA regulation of dietary supplements and requirements regarding adverse event reporting. Clin Pharmacol Ther. 2010;87(2):239-244.
4. 21 Code of Federal Regulations Part 111. Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements; Final Rule, Department of Health and Human Services, Food and Drug Administration. June 25, 2007.
5. Federal Food, Drug and Cosmetic Act. Sec. 413 [21 USC §350b]. New Dietary Ingredients.
6. National Center for Complementary and Alternative Medicine, National Institutes of Health, Department of Health and Human Services. http://nccam.nih.gov/health/whatiscam/overview.htm. Accessed February 26, 2010.
7. Reist RH, Dey RD, Durham JP, Rojanasakul Y, Castranova V. Inhibition of proliferative activity of pulmonary fibroblasts by tetrandrine. Toxicol Appl Pharmacol. 1993;122(1):70-76.
8. Lockie A. Encyclopedia of Homeopathy. New York, NY: Dorling Kindersley; 2000.
9. Malone D, Bhandary D. Factors associated with medication use among the elderly. Abstr Acad Health Serv Res Health Policy Meet. 2001;18:157.
10. Vogel JH, Bolling SF, Costello RB, et al. Integrating complementary medicine into cardiovascular medicine: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2005;46:184-221.
11. ABC Responds to Article on Herb-Drug Interactions in Journal of the American College of Cardiology.